Published in Clin Pharmacol Ther on August 01, 1992
Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomised controlled trial. BMJ (2008) 5.71
Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology (2009) 1.19
Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children. Br J Clin Pharmacol (1998) 1.10
Knowledge, attitudes and misconceptions of primary care physicians regarding fever in children: a cross sectional study. Ital J Pediatr (2012) 0.99
Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid. Br J Clin Pharmacol (1995) 0.89
Paracetamol: a focus for the general pediatrician. Eur J Pediatr (2013) 0.87
Recent Advances in Pediatric Use of Oral Paracetamol in Fever and Pain Management. Pain Ther (2015) 0.81
Acetaminophen and ibuprofen in the management of fever and mild to moderate pain in children. Paediatr Child Health (1998) 0.81
Stereoselective disposition of ibuprofen enantiomers in infants. Br J Clin Pharmacol (1994) 0.81
Oral-ibuprofen-induced acute renal failure in a preterm infant. Pediatr Nephrol (2008) 0.81
The effects and safety of dexibuprofen compared with ibuprofen in febrile children caused by upper respiratory tract infection. Br J Clin Pharmacol (2008) 0.81
Intravenous ibuprofen: the first injectable product for the treatment of pain and fever. J Pain Res (2010) 0.77
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Paracetamol or ibuprofen in febrile children. J Accid Emerg Med (1999) 0.75
Efficacy and Safety of Ibuprofen in Infants Aged Between 3 and 6 Months. Paediatr Drugs (2017) 0.75
A 1.5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome. Nat Genet (2001) 4.58
Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection. Arch Dis Child (2001) 2.07
Percutaneous revascularization of atherosclerotic obstruction of aortic arch vessels. J Am Coll Cardiol (1999) 1.88
Efficacy of personal symptom and family history questionnaires when screening for inherited cardiac pathologies: the role of electrocardiography. Br J Sports Med (2007) 1.78
Prenatal maternal blood pressure response to stress predicts birth weight and gestational age: a preliminary study. Am J Obstet Gynecol (1996) 1.59
Human chorionic gonadotropin: its possible role in maternal lymphocyte suppression. Science (1973) 1.59
Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of three poliovirus serotypes. Structure (1997) 1.52
A binary complex of the catalytic subunit of cAMP-dependent protein kinase and adenosine further defines conformational flexibility. Structure (1997) 1.51
Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine. Biochemistry (1997) 1.50
Dynamic changes in HIV-1 quasispecies from azidothymidine (AZT)-treated patients. FASEB J (1992) 1.41
The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci. Genomics (1992) 1.40
Practice guideline for examination of the placenta: developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med (1997) 1.40
Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera. J Virol (1992) 1.39
600 ps molecular dynamics reveals stable substructures and flexible hinge points in cAMP dependent protein kinase. Biopolymers (1999) 1.32
Dissection of the nucleotide and metal-phosphate binding sites in cAMP-dependent protein kinase. Biochemistry (1999) 1.29
Ten guiding principles for teaching children and adolescents about medicines. US Pharmacopeia. Clin Ther (1999) 1.29
Longitudinal study of levodopa/carbidopa for childhood amblyopia. J Pediatr Ophthalmol Strabismus (1994) 1.28
Drug susceptibility of subtypes A,B,C,D, and E human immunodeficiency virus type 1 primary isolates. AIDS Res Hum Retroviruses (1998) 1.27
Proceed with care: direct predictive testing for Huntington disease. Am J Hum Genet (1994) 1.25
Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies. Intern Med J (2010) 1.23
Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine (2002) 1.20
Large linkage analysis in 100 families with autosomal recessive spinal muscular atrophy (SMA) and 11 CEPH families using 15 polymorphic loci in the region 5q11.2-q13.3. Genomics (1994) 1.18
Conserved water molecules contribute to the extensive network of interactions at the active site of protein kinase A. Proc Natl Acad Sci U S A (1998) 1.18
SCH 48973: a potent, broad-spectrum, antienterovirus compound. Antimicrob Agents Chemother (1997) 1.17
Home oxygen status and rehospitalisation and primary care requirements of infants with chronic lung disease. Arch Dis Child (2002) 1.15
Hydrolysis and protein binding of melphalan. J Pharm Sci (1978) 1.10
The mechanism of action of the anti-herpes virus compound 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline. Antiviral Res (1991) 1.10
Levodopa/carbidopa treatment for amblyopia in older children. J Pediatr Ophthalmol Strabismus (1995) 1.08
Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea. J Clin Virol (1999) 1.08
A new scale to assess radiographic success of secondary alveolar bone grafts. Cleft Palate Craniofac J (2002) 1.07
Theophylline poisoning. J Pediatr (1977) 1.06
Acute and chronic neuropsychological consequences of mercury vapor poisoning in two early adolescents. J Clin Exp Neuropsychol (1994) 1.05
Primary biliary cirrhosis in mother and daughter. Br Med J (1977) 1.04
Acute effects of aerobic exercise on mood. Health Psychol (1988) 1.04
Occlusion and levodopa-carbidopa treatment for childhood amblyopia. J AAPOS (1998) 1.02
The nature and assessment of general well-being. J Psychosom Res (1983) 1.02
Seizures secondary to oral viscous lidocaine. Ann Emerg Med (1988) 1.00
Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART? Br J Cancer (2003) 1.00
Backbone flexibility of five sites on the catalytic subunit of cAMP-dependent protein kinase in the open and closed conformations. Biochemistry (1998) 0.99
High-pressure liquid chromatographic analysis of melphalan in plasma. J Pharm Sci (1978) 0.99
Estimating the prevalence of problem drug use in inner London: a discussion of three capture-recapture studies. Addiction (1999) 0.98
Measurement of acetaminophen-protein adducts in children and adolescents with acetaminophen overdoses. . J Clin Pharmacol (2001) 0.98
Detection of first-order liquid/liquid phase transitions in yttrium oxide-aluminum oxide melts. Science (2008) 0.98
Intrapatient variability in theophylline kinetics. J Pediatr (1977) 0.97
Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Annu Rev Med (2000) 0.97
A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein. Cancer Res (2001) 0.97
From sequence to chromosome: the tip of the X chromosome of D. melanogaster. Science (2000) 0.96
Levodopa/carbidopa for childhood amblyopia. Invest Ophthalmol Vis Sci (1993) 0.95
The need for palliative care for patients with non-cancer diseases: a review of the evidence. Int J Palliat Nurs (2001) 0.95
Towards efficient guidelines: how to monitor guideline use in primary care. Health Technol Assess (2003) 0.95
Enteral feeding: practice guidance. Paediatr Nurs (2000) 0.95
Parental concern and distress about infant pain. Arch Dis Child Fetal Neonatal Ed (2004) 0.95
Development of a panel of monochromosomal somatic cell hybrids for rapid gene mapping. Ann Hum Genet (1995) 0.93
Identification of selective inhibitors of cyclin dependent kinase 4. Bioorg Med Chem Lett (2001) 0.93
Functional malleability of the carboxyl-terminal tail in protein kinase A. J Biol Chem (1996) 0.93
Meta-analysis on the efficacy of foot-and-mouth disease emergency vaccination. Prev Vet Med (2011) 0.92
High-resolution molecular characterization of the HLA class I and class II in the Tarahumara Amerindian population. Tissue Antigens (2006) 0.92
HIV-1 drug susceptibilities and reverse transcriptase mutations in patients receiving combination therapy with didanosine and delavirdine. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.92
Technical report: precautions regarding the use of aerosolized antibiotics. Committee on Infectious Diseases and Committee on Drugs. Pediatrics (2000) 0.91
Fatal ingestion of boric acid in an adult. Am J Emerg Med (1992) 0.91
Dementia care provision in rural Scotland: service users' and carers' experiences. Health Soc Care Community (2005) 0.90
Evaluation of a monoclonal antibody-based approach for the selection of foot-and-mouth disease (FMD) vaccine strains. Vet Microbiol (2007) 0.90
Experimental studies with foot-and-mouth disease virus, strain O, responsible for the 2001 epidemic in the United Kingdom. Vaccine (2002) 0.89
Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis. Chest (1997) 0.89
Report and abstracts of the Fourth International Workshop on Human Chromosome 2 Mapping 1996. Cytogenet Cell Genet (1996) 0.89
Phenytoin kinetics in children. Neurology (1976) 0.89
Synergistic inhibition of human immunodeficiency virus replication in vitro by combinations of 3'-azido-3'-deoxythymidine and 3'-fluoro-3'-deoxythymidine. AIDS Res Hum Retroviruses (1990) 0.88
Evidence for the absence of intron H of the histidine-rich glycoprotein (HRG) gene: genetic mapping and in situ localization of HRG to chromosome 3q28-q29. Genomics (1994) 0.88
Complications of cholecystectomy in district general hospitals. Br J Clin Pract (1990) 0.88
Porcine gammadelta T cells: possible roles on the innate and adaptive immune responses following virus infection. Vet Immunol Immunopathol (2006) 0.88
Lidocaine and mepivacaine in cord blood. Pediatr Pharmacol (New York) (1982) 0.87
Systemic toxicity following gasoline aspiration. Am J Emerg Med (1983) 0.87
Continuous insulin infusion in hyperglycemic, very low birth weight infants. J Pediatr Gastroenterol Nutr (1982) 0.87
Diagnosis of heart failure in elderly patients in primary care. Eur J Heart Fail (2001) 0.87
CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity. Clin Chim Acta (2013) 0.86
Impact of a multiple, IVF birth on post-partum mental health: a composite analysis. Hum Reprod (2007) 0.86
Pharmacokinetics of phenytoin in children with acute neurotrauma. Crit Care Med (1995) 0.85
A DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth disease. Antiviral Res (2012) 0.85
Kids are different: developmental variability in toxicology. Toxicology (1996) 0.85
Weak charge-lattice coupling requires reinterpretation of stripes of charge order in La1-xCaxMnO3. Phys Rev Lett (2005) 0.85
Hormone-responsive creatine kinase in normal and neoplastic mammary glands. Ann N Y Acad Sci (1986) 0.84
Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1. Antimicrob Agents Chemother (1989) 0.84
Yield drag in a two-dimensional foam flow around a circular obstacle: effect of liquid fraction. Eur Phys J E Soft Matter (2007) 0.84
Increased activation of the combination of 3'-azido-3'-deoxythymidine and 2'-deoxy-3'-thiacytidine in the presence of hydroxyurea. Antimicrob Agents Chemother (1997) 0.83
Human chorionic gonadotropin: inhibitory effect on mixed lymphocyte cultures. Gynecol Invest (1973) 0.83
Immune mechanisms in leukemia: suppression of cellular immunity by starvation. J Natl Cancer Inst (1975) 0.83
Human lymphocytes resistant to 6-thioguanine increase with age. Mech Ageing Dev (1982) 0.83
The CEPH consortium linkage map of human chromosome 11. Genomics (1995) 0.83
Comparison of extraction procedures for high-performance liquid chromatographic determination of cellular deoxynucleotides. J Chromatogr A (1994) 0.83
Development of a Physiologically-Based Pharmacokinetic Model for Sirolimus: Predicting Bioavailability Based on Intestinal CYP3A Content. CPT Pharmacometrics Syst Pharmacol (2013) 0.83
Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABC. Vet Microbiol (2004) 0.83
Haematoma of rectus abdominis from the use of an exercise wheel: a report of 3 cases. Br J Surg (1974) 0.83
Safety of vancomycin with or without gentamicin in neonates. Neonatal Netw (1993) 0.83
Succimer chelation: what is known? J Pediatr (1994) 0.82
Preoperative evaluation of abnormal mammographic findings to avoid unnecessary breast biopsies. Arch Surg (1994) 0.82
Systems for implementing best practice for a chronic disease: management of osteoarthritis of the hip and knee. Intern Med J (2006) 0.82
Bowel rehabilitation: an alternative to long-term parenteral nutrition and intestinal transplantation for some patients with short bowel syndrome. Transplant Proc (2002) 0.82
High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest. Resuscitation (1995) 0.82
Quinazolines as cyclin dependent kinase inhibitors. Bioorg Med Chem Lett (2001) 0.81
Improved sample preparation method for high-performance liquid chromatography of deoxyribonucleoside triphosphates from cell culture extracts. J Chromatogr (1990) 0.81